Theophilos Tzaridis

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 01, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations.

Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang

|Jan 07, 2023
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

J Weller, N Schäfer, C Schaub

|Sep 02, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.

Theophilos Tzaridis, Johannes Weller, Daniel Bachurski

|Sep 10, 2021
Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic Applications.

Theophilos Tzaridis, Daniel Bachurski, Shu Liu

|Oct 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.

Theophilos Tzaridis, Niklas Schäfer, Johannes Weller

Pageof 1

Frequent Collaborators

2 joint publications

Daniel Bachurski

2 joint publications

Katrin S Reiners

1 joint publications

J Weller

1 joint publications

M Schneider